期刊
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
卷 38, 期 12, 页码 861-866出版社
OXFORD UNIV PRESS
DOI: 10.1093/jjco/hyn111
关键词
-
类别
资金
- Medical Science and Technology Research Foundation [06MA27]
Transforming growth factor-beta 1 (TGF-beta 1) inhibits the proliferation of tumors in early stages of cancers, whereas it promotes tumor growth and metastasis in later stages of cancers. To examine the effect of the TGF-beta 1 polymorphisms on gastric cancer risk, we studied the association between C-509T and T+29C (Leu10Pro) polymorphisms in TGF-beta 1 and gastric cancer risk in 414 cases and 414 controls in the Chinese population. When the overall gastric cancer cases were compared with the controls, no significant difference was found in genotype distributions for both the polymorphisms examined. However, when stratified by tumor stage, the -509T and +29C allele carriers had a 0.57-fold (95% CI = 0.36-0.90) and a 0.58-fold (95% CI = 0.36-0.91) decreased risk of TNM stage I+II gastric cancer, respectively, as compared with non-carriers. We conclude that TGF-beta 1-509T and +29C alleles may have a protective role in the development of stage I+II gastric cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据